Is VRTX up or down today?
VRTX is up 0.17% today, last at 515.44. This stock moved +0.17% versus the prior close.
VRTX · Vertex Pharmaceuticals
VRTX (Vertex Pharmaceuticals) is trading at 515.44, up 0.17% on the session. VRTX sits at the 76% mark of its 52-week range, carries a 14-day RSI of 44, and trades above its 50-day average. Over the past month it is down 1.96%.
Leading the coverage: “Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know” (Yahoo, 3d ago). VRTX is -5.62% since story.
VRTX trades on a trailing P/E of 30.0 and is running 0.90% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
VRTX is up 0.17% today, last at 515.44. This stock moved +0.17% versus the prior close.
Leading the coverage: “Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know” (Yahoo, 3d ago). VRTX is -5.62% since story. Dominant story: Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis (1 source, bullish) RSI is 44 — leaning bearish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (126 days) · Drag or scroll left for earlier dates
Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis
Why Vertex Pharmaceuticals (VRTX) Is Getting Attention Today - simplywall.st
Vertex Pharma stock gains analyst support as JPMorgan raises price target - ad-hoc-news.de
Vertex trades higher after JPM gives bullish rating - TradingView
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher